 | Up a level |
Granholm, Anders; Kjær, Maj-Brit Nørregaard; Munch, Marie Warrer; Myatra, Sheila Nainan; Vijayaraghavan, Bharath Kumar Tirupakuzhi; Cronhjort, Maria; Wahlin, Rebecka Rubenson; Jakob, Stephan M; Cioccari, Luca; Vesterlund, Gitte Kingo; Meyhoff, Tine Sylvest; Helleberg, Marie; Møller, Morten Hylander; Benfield, Thomas; Venkatesh, Balasubramanian; Hammond, Naomi E; Micallef, Sharon; Bassi, Abhinav; John, Oommen; Jha, Vivekanand; ... (2022). Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia. Intensive care medicine, 48(5), pp. 580-589. Springer 10.1007/s00134-022-06677-2
Munch, Marie W; Myatra, Sheila N; Vijayaraghavan, Bharath Kumar Tirupakuzhi; Saseedharan, Sanjith; Benfield, Thomas; Wahlin, Rebecka R; Rasmussen, Bodil S; Andreasen, Anne Sofie; Poulsen, Lone M; Cioccari, Luca; Khan, Mohd S; Kapadia, Farhad; Divatia, Jigeeshu V; Brøchner, Anne C; Bestle, Morten H; Helleberg, Marie; Michelsen, Jens; Padmanaban, Ajay; Bose, Neeta; Møller, Anders; ... (2021). Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial. JAMA : the journal of the American Medical Association, 326(18), pp. 1807-1817. American Medical Association 10.1001/jama.2021.18295
